Arvee Laboratories (India) Ltd. (NSE:ARVEE)

India · Delayed Price · Currency is INR

219.00

-6.16 (-2.74%)

Oct 1, 2026, 3:29 PM IST

Market Cap	2.37B +39.1%
Revenue (ttm)	412.59M +16.7%
Net Income	40.51M +194.8%
EPS	3.70 +197.4%
Shares Out	11.02M
PE Ratio	58.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,676
Open	232.99
Previous Close	225.16
Day's Range	207.00 - 232.99
52-Week Range	129.11 - 290.78
Beta	0.55
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 2012

Employees 57

Stock Exchange National Stock Exchange of India

Ticker Symbol ARVEE

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:ARVEE's revenue was 315.14 million, a decrease of -18.12% compared to the previous year's 384.87 million. Earnings were 25.26 million, an increase of 17.65%.

Financial Statements